IZZI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 9.028
EU - Europa 747
AS - Asia 277
SA - Sud America 12
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.073
Nazione #
US - Stati Uniti d'America 9.010
IE - Irlanda 192
IT - Italia 146
DE - Germania 111
KR - Corea 107
CN - Cina 97
UA - Ucraina 76
GB - Regno Unito 65
RU - Federazione Russa 49
SG - Singapore 44
FR - Francia 26
FI - Finlandia 18
CA - Canada 17
CZ - Repubblica Ceca 17
SE - Svezia 15
NL - Olanda 9
BE - Belgio 7
BR - Brasile 6
JP - Giappone 6
AU - Australia 4
CH - Svizzera 4
IN - India 4
EU - Europa 3
HU - Ungheria 3
AR - Argentina 2
HK - Hong Kong 2
IR - Iran 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PL - Polonia 2
TH - Thailandia 2
AT - Austria 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TR - Turchia 1
TW - Taiwan 1
Totale 10.073
Città #
Wilmington 2.559
Houston 2.454
Woodbridge 1.581
Fairfield 407
Chandler 331
Ashburn 264
Seattle 193
Dublin 165
Cambridge 159
Ann Arbor 149
Medford 115
New York 104
Rome 73
Dearborn 72
Beijing 67
Lawrence 54
Menlo Park 40
San Diego 34
Jacksonville 32
Moscow 24
Boardman 21
Singapore 20
Brno 17
Seoul 15
London 13
Redwood City 13
Norwalk 12
Toronto 12
Kilburn 9
Milan 9
Zhengzhou 8
Brussels 7
Palo Alto 7
Creede 6
Munich 6
Philadelphia 6
San Francisco 6
São Paulo 6
Washington 6
Hounslow 5
Nanjing 5
Amsterdam 4
Chicago 4
Council Bluffs 4
Engelhard 4
Kunming 4
Pune 4
Redmond 4
Roebling 4
Verona 4
Atlanta 3
Budapest 3
Columbus 3
Florence 3
Huskvarna 3
Islington 3
Lappeenranta 3
Nashville 3
Nuremberg 3
Prescot 3
Solofra 3
Tokyo 3
Walton on Thames 3
Alderley Edge 2
Apeldoorn 2
Auckland 2
Bangkok 2
Bologna 2
Capranica 2
Colombo 2
Dallas 2
Doganella 2
Enfield 2
Helsinki 2
Kraków 2
La Veta 2
Las Vegas 2
Lima 2
Lucca 2
Manila 2
Mountain View 2
Nanchang 2
New Bedfont 2
Palermo 2
Phoenix 2
Pisa 2
Rozzano 2
Saint Petersburg 2
Salt Lake City 2
San Jose 2
San Mateo 2
Sant'Angelo dei Lombardi 2
Southwark 2
Thornhill 2
Yreka 2
Adliswil 1
Almaty 1
Andover 1
Ashdod 1
Athens 1
Totale 9.230
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 446
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 446
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 435
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 402
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 401
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 386
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 385
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 373
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 354
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 342
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 337
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 335
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 335
Obstructive sleep apnoea and bone health 313
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 308
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 297
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 259
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 241
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 209
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 188
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 187
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 181
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 180
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 176
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 174
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 173
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 173
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 167
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 162
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 149
Seasonality of restless legs syndrome: symptom variability in winter and summer times 146
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 143
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies 140
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 133
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 127
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 109
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 105
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 95
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 63
Heart Rate Variability Parameters During Psychogenic Non-epileptic Seizures: Comparison Between Patients With Pure PNES and Comorbid Epilepsy 54
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 49
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 48
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 47
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 47
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 38
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 38
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 38
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 34
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 32
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 30
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 28
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 28
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 24
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 24
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 23
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 19
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 18
Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study 17
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 17
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 17
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 14
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 13
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance 13
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 11
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study 9
Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease 8
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 6
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 5
Totale 10.324
Categoria #
all - tutte 27.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.981 176 165 128 214 200 229 214 389 373 351 282 260
2020/20212.411 282 280 265 289 236 300 295 224 43 106 68 23
2021/2022661 27 46 26 11 16 18 65 15 33 53 40 311
2022/2023882 103 77 41 105 73 177 77 60 85 16 37 31
2023/2024474 54 10 25 23 39 158 21 37 8 27 8 64
2024/202551 51 0 0 0 0 0 0 0 0 0 0 0
Totale 10.324